TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3235927

Group type: EXPERIMENTAL
Intervention: Cervical adjusting
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Gluteal massage
Number of subjects: 26

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 26
Study: 29395018

Group type: EXPERIMENTAL
Intervention: Video feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional feedback
Number of subjects: 0
Study: 27761966

Group type: EXPERIMENTAL
Intervention: Occupational Therapy Task-Oriented (TO) intervention for 6 weeks, 3 hours per week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 24097288

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin plus low-intensity warfarin (LDA + W)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Observational arm (LDA)
Number of subjects: 166
Study: 24160231

Group type: EXPERIMENTAL
Intervention: Diet with daily supplementation of 10,000 IU of vitamin A, 400 mg of vitamin E, and 600 mg of vitamin C (G2)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard diet (G1)
Number of subjects: 34
Study: 21923449

Group type: EXPERIMENTAL
Intervention: Metoprolol ER 100 mg with paroxetine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Metoprolol ER 200 mg with paroxetine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Metoprolol IR (two 100 mg doses) with paroxetine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Metoprolol IR with paroxetine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 15
Study: 18312046

Group type: EXPERIMENTAL
Intervention: LETS Act! (brief behavioral therapy for depression)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 44
Study: 16597655

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propofol 20 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Alizapride 100 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Promethazine 50 mg
Number of subjects: 300

Group type: COMPARATOR
Intervention: Saline 2 ml (control group)
Number of subjects: 300
Study: 12971812

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11079089

Group type: EXPERIMENTAL
Intervention: GPW mixture (gelatin, Peritrast, and water) administered over an intestinal tube
Number of subjects: 20

Group type: COMPARATOR
Intervention: Small bowel enema
Number of subjects: 20

Group type: COMPARATOR
Intervention: SBFT
Number of subjects: 20
Study: 8837238

Group type: EXPERIMENTAL
Intervention: 3.75 mg leuprolide depot intramuscularly every 28 days for 24 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1608407

Group type: EXPERIMENTAL
Intervention: Phenytoin treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study: 555483

Group type: EXPERIMENTAL
Intervention: Reinterpreting the pain stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diverting one's attention from pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concentrating on the sensation itself
Number of subjects: 0
Study: 31148492

Group type: EXPERIMENTAL
Intervention: Acute dietary nitrate supplementation (6.2 mmol), 2 hours prior to testing
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 28976426

Group type: EXPERIMENTAL
Intervention: TXA
Number of subjects: 194

Group type: COMPARATOR
Intervention: EACA
Number of subjects: 194
Study: 26033430

Group type: EXPERIMENTAL
Intervention: Intervention (Project SHARE) - personalized reports, educational materials, drinking diaries, in-person physician advice, telephone counseling by health educators (HEs)
Number of subjects: 1186

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 1186
Study: 24043751

Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg
Number of subjects: 1432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1432

Group type: COMPARATOR
Intervention: Overall study population
Number of subjects: 1432
Study: 21316647

Group type: EXPERIMENTAL
Intervention: Ineffectiveness induction (participants recalled a past experience when they felt useless or incapable)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ineffectiveness induction
Number of subjects: 120
Study: 20032953

Group type: EXPERIMENTAL
Intervention: Cereton (1000 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Piracetam (2000 mg)
Number of subjects: 60
Study: 16762944

Group type: EXPERIMENTAL
Intervention: Phenylalanine intake of 38 mg . kg(‐1) . d(‐1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Phenylalanine intake of 37 mg . kg(‐1) . d(‐1)
Number of subjects: 32
Study: 17273582

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 31

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 31
Study: 14992111

Group type: EXPERIMENTAL
Intervention: Modified technique for radial artery harvesting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard technique for radial artery harvesting
Number of subjects: 0
Study: 10204971

Group type: EXPERIMENTAL
Intervention: General anxiety
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Breast cancer worries
Number of subjects: 833
Study: 8665998

Group type: EXPERIMENTAL
Intervention: Conventional rapid release preparation of oxipurinol sodium
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oxipurinol as free acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enteric coated microtablets of oxipurinol sodium
Number of subjects: 10

Group type: COMPARATOR
Intervention: Allopurinol (300 mg)
Number of subjects: 10
Study: 2218006

Group type: EXPERIMENTAL
Intervention: Enprofylline 150 mg bd for 2 weeks, then 300 mg bd for 3 weeks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Theophylline 150 mg bd for 2 weeks, then 300 mg bd for 3 weeks
Number of subjects: 85
Study: 7446916

Group type: EXPERIMENTAL
Intervention: Enflurane anaesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Halothane anaesthesia
Number of subjects: 100
Study: 29650037

Group type: EXPERIMENTAL
Intervention: Experimental schedule 2/1 (50 mg daily)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Standard schedule 4/2 (37.5 mg daily)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Both schedules
Number of subjects: 248
Study: 28829877

Group type: EXPERIMENTAL
Intervention: Ganciclovir
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 26699730

Group type: EXPERIMENTAL
Intervention: Affect Consciousness (AC) intervention
Number of subjects: 52
Study: 23263000

Group type: EXPERIMENTAL
Intervention: GS-9851 400 mg once daily for 3 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 21400557

Group type: EXPERIMENTAL
Intervention: Reduced carbohydrate diet (n = 84)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Reduced fat diet (n = 86)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Both diets (reduced carbohydrate and reduced fat)
Number of subjects: 170
Study: 18190557

Group type: EXPERIMENTAL
Intervention: CTG+PRP
Number of subjects: 40

Group type: COMPARATOR
Intervention: CTG
Number of subjects: 40
Study: 16137833

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler, bupropion, or both for smoking cessation
Number of subjects: 1692
Study: 12829988

Group type: EXPERIMENTAL
Intervention: Ribavirin (1,000-1,200 mg daily)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 10996722

Group type: EXPERIMENTAL
Intervention: Chemotherapy (n=20; 1052 lymph nodes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Surgery (n=20; 929 lymph nodes)
Number of subjects: 40
Study: 8898828

Group type: EXPERIMENTAL
Intervention: recombinant tissue plasminogen activator (rt-PA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 1797498

Group type: EXPERIMENTAL
Intervention: Human ultralente insulin before supper
Number of subjects: 20

Group type: COMPARATOR
Intervention: NPH (isophane) before breakfast
Number of subjects: 20
Study: 6617072

Group type: EXPERIMENTAL
Intervention: 3 mg lorazepam
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30545786

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Interscalene nerve block (ISB)
Number of subjects: 99
Study: 27927601

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25641899

Group type: EXPERIMENTAL
Intervention: Resilience Training
Number of subjects: 1939

Group type: COMPARATOR
Intervention: Military History
Number of subjects: 1939
Study: 24347664

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with a defibrillator (CRT-D)
Number of subjects: 1785

Group type: COMPARATOR
Intervention: Defibrillator-only therapy
Number of subjects: 1785
Study: 21890585

Group type: EXPERIMENTAL
Intervention: TPA023 (2 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Alcohol (0.6 g/L)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 19652099

Group type: EXPERIMENTAL
Intervention: 21-lesson curriculum delivered during 28 hours by trained teachers
Number of subjects: 1722

Group type: COMPARATOR
Intervention: Control schools targeted similar objectives without training or materials
Number of subjects: 1722
Study: 17475735

Group type: EXPERIMENTAL
Intervention: Weekly interpersonal psychotherapy (IPT)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Twice-monthly interpersonal psychotherapy (IPT)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Monthly interpersonal psychotherapy (IPT)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: IPT with selective serotonin reuptake inhibitor (SSRI)
Number of subjects: 233
Study: 15025617

Group type: EXPERIMENTAL
Intervention: 6 mg of bupivacaine and 50 microg of morphine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 6 mg of bupivacaine and 25 microg of fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: 6 mg of bupivacaine and saline
Number of subjects: 60
Study: 11283120

Group type: EXPERIMENTAL
Intervention: Topotecan (1.5 mg/m²/day for 5 days every 21 days)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m² over 3 hours every 21 days)
Number of subjects: 226
Study: 9258981

Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cloxacillin and Diclofenac
Number of subjects: 15
Study: 7685226

Group type: EXPERIMENTAL
Intervention: Tenidap sodium (40-120 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen (1000 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3808505

Group type: EXPERIMENTAL
Intervention: Prompt delivery (N = 26)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conservative management (N = 21)
Number of subjects: 99
Study: 30614315

Group type: EXPERIMENTAL
Intervention: Zhukovsky obstetric double balloon
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional hysterectomy
Number of subjects: 41
Study: 29772695

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BoNT‐A) injections
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline injections
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: BoNT‐A injections
Number of subjects: 16
Study: 26460205

Group type: EXPERIMENTAL
Intervention: Colonic mucosal microbiota
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fecal microbiota
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Methane production
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Colonic transit
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall composition of colonic mucosal microbiota
Number of subjects: 50
Study: 25308064

Group type: EXPERIMENTAL
Intervention: 0.5mg estradiol cypionate (EC)
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: 1.0mg estradiol cypionate (EC)
Number of subjects: 691

Group type: COMPARATOR
Intervention: 1.0mg estradiol benzoate (EB)
Number of subjects: 691
Study: 22398127

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg/d
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 20696552

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 434

Group type: COMPARATOR
Intervention: Lamotrigine
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study: 18410386

Group type: EXPERIMENTAL
Intervention: Emdogain
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study: 16112784

Group type: EXPERIMENTAL
Intervention: RBD patients with visual neglect
Number of subjects: 33

Group type: COMPARATOR
Intervention: RBD patients without neglect
Number of subjects: 33

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 33
Study: 14671468

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 325

Group type: COMPARATOR
Intervention: Simvastatin 40 mg/day
Number of subjects: 325
Study: 11692340

Group type: EXPERIMENTAL
Intervention: Adhesive amalgam restorations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bonding of amalgam restorations
Number of subjects: 0
Study: 7723447

Group type: EXPERIMENTAL
Intervention: Nottingham Health Profile (NHP)
Number of subjects: 0
Study: 2254512

Group type: EXPERIMENTAL
Intervention: Behavioral Marital Therapy (BMT) Alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR) + BMT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BMT + Emotional Expressiveness Training (EET)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CR + BMT + EET
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting List
Number of subjects: 60
Study: 6118980

Group type: EXPERIMENTAL
Intervention: Talinolol (cordanum) administered intravenously and then orally
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Talinolol (cordanum)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 9
Study: 31211381

Group type: EXPERIMENTAL
Intervention: Highest quartile of FABP4
Number of subjects: 2194

Group type: EXPERIMENTAL
Intervention: Highest quartile of FABP4 in men
Number of subjects: 2194

Group type: EXPERIMENTAL
Intervention: Highest quartile of FABP4 in women
Number of subjects: 2194
Study: 29802093

Group type: EXPERIMENTAL
Intervention: Computer-based Driving in Dementia Decision Tool (DD-DT)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control version of the tool (generic reminder about reporting legislation)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Caregiver concern
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Abnormal clock drawing
Number of subjects: 217
Study: 26253746

Group type: EXPERIMENTAL
Intervention: e-virtual reality exposure therapy (remote sessions)
Number of subjects: 6

Group type: COMPARATOR
Intervention: traditional virtual reality exposure therapy (in-person sessions)
Number of subjects: 6
Study: 24514431

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study: 22652990

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections of local anesthetic (lidocaine 0.5%)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with 0.5% lidocaine mixed with 1 mL of steroid (nonparticulate Celestone)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (Group I and Group II)
Number of subjects: 100
Study: 20012609

Group type: EXPERIMENTAL
Intervention: LVA (Left Ventricular-Assisted technique)
Number of subjects: 40

Group type: COMPARATOR
Intervention: CPB (Conventional Cardiopulmonary Bypass)
Number of subjects: 40
Study: 18587253

Group type: EXPERIMENTAL
Intervention: T1a tumor group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: T1b tumor group
Number of subjects: 105

Group type: COMPARATOR
Intervention: Fascin-1 positivity
Number of subjects: 105

Group type: COMPARATOR
Intervention: Extent of lamina propria invasion
Number of subjects: 105
Study: 16135166

Group type: EXPERIMENTAL
Intervention: Nedocromil (8 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12350428

Group type: EXPERIMENTAL
Intervention: Fast charge (fc: 1.0 Coulomb/s) stimulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Slow charge (sc: 0.1 Coulomb/s) stimulation
Number of subjects: 18
Study: 10028136

Group type: EXPERIMENTAL
Intervention: New model involving dependence between lead-time and post-lead-time survival
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-parametric maximum likelihood estimator of post-lead-time survival
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening
Number of subjects: 0
Study: 7598235

Group type: EXPERIMENTAL
Intervention: Carbonated lidocaine (20 mL of 1.73% carbonated lidocaine with epinephrine 5 micrograms/mL plus 2 mL of 0.9% NaCl, pH 6.42 +/- 0.04)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: pH adjusted lidocaine (20 mL of lidocaine with epinephrine 5 micrograms/mL plus 2 mL of 8.4% sodium bicarbonate, pH 6.47 +/- 0.16)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lidocaine HCl (control group, 20 mL of 2% lidocaine with epinephrine 5 micrograms/mL plus 2 mL of NaCl 0.9%, pH 4.58 +/- 0.10)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lidocaine HCl
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Carbonated lidocaine
Number of subjects: 45
Study: 2369808

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (0.5 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Norepinephrine (locally infused)
Number of subjects: 17
Study: 146524

Group type: EXPERIMENTAL
Intervention: Intravenous physostigmine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Choline chloride
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Chronic treatment with oral choline chloride
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Single 5-g dose of choline chloride
Number of subjects: 25
Study: 6127747

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 75 mg
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: COMPARATOR
Intervention: Diazepam 15 mg
Number of subjects: 55

Group type: COMPARATOR
Intervention: Imipramine 50 mg
Number of subjects: 55
Study: 31272408

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal tDCS (20 min, 2 mA, ramp‐up and down periods of 30 s each, delivered over ten sessions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham cerebellar tDCS
Number of subjects: 20
Study: 29737796

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme 8371 USP unit of lipase, 3 times daily for 1 month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26931347

Group type: EXPERIMENTAL
Intervention: Supplemented group received 400 IU of RRR‐α‐tocopheryl acetate.
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no supplementation).
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Supplemented group.
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 89
Study: 24131304

Group type: EXPERIMENTAL
Intervention: 5 mg/kg lebrikizumab administered subcutaneously every 4 weeks over 12 weeks (total of four doses)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo administered subcutaneously every 4 weeks over 12 weeks (total of four doses)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 5 mg/kg lebrikizumab
Number of subjects: 29
Study: 22841233

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 20604695

Group type: EXPERIMENTAL
Intervention: Team-centered peer-taught curriculum
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Individual motivational interviewing intervention
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 599
Study: 18057361

Group type: EXPERIMENTAL
Intervention: Cemented fixation
Number of subjects: 501

Group type: COMPARATOR
Intervention: Cementless fixation
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Cemented fixation (males)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Cementless fixation (males)
Number of subjects: 501
Study: 15604157

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics at home
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous antibiotics in hospital
Number of subjects: 200
Study: 11862350

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Remacemide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 10191283

Group type: EXPERIMENTAL
Intervention: Stanol ester margarine (2 or 3 g/day)
Number of subjects: 153
Study: 8703669

Group type: EXPERIMENTAL
Intervention: theophylline + 200 mg nefazodone twice daily (every 12h)
Number of subjects: 13

Group type: COMPARATOR
Intervention: theophylline + matching nefazodone placebo capsule twice daily (every 12h)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: theophylline + 200 mg nefazodone
Number of subjects: 13

Group type: COMPARATOR
Intervention: theophylline + matching nefazodone placebo
Number of subjects: 13
Study: 2203256

Group type: EXPERIMENTAL
Intervention: Low-glycemic-effect (LGE) meal
Number of subjects: 6

Group type: COMPARATOR
Intervention: High-glycemic-effect (HGE) meal
Number of subjects: 6
Study: 457892

Group type: EXPERIMENTAL
Intervention: Rolfing (Structural Integration)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 29203209

Group type: EXPERIMENTAL
Intervention: BTHC-PCB
Number of subjects: 264

Group type: COMPARATOR
Intervention: iopromide-PCB
Number of subjects: 264
Study: 26329841

Group type: EXPERIMENTAL
Intervention: Below CRI
Number of subjects: 12

Group type: COMPARATOR
Intervention: Above CRI
Number of subjects: 12
Study: 25532515

Group type: EXPERIMENTAL
Intervention: rFSH + GnRH antagonist (n = 45)
Number of subjects: 108

Group type: COMPARATOR
Intervention: rFSH (n = 63)
Number of subjects: 108